NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it will exhibit at the annual meeting of The Endocrine Society in Boston on June 4-6, 2011. The exhibition will include a demonstration of its newest product - NC-stat®|DPNCheck™ which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy (DPN).
